Skip to main content
TipRanks
Go Ultimate75% OFF

Noah G. Levy Insider Profile

32 Followers

Noah G. Levy, former Director, See remarks at Merrimack Pharmaceuticals, holds 1.12M shares in Merrimack Pharmaceuticals (Ticker: MACK). Most recently, Noah G. Levy Bought 100,000 shares of Merrimack Pharmaceuticals on Jan 17, 2023 for an estimated value of $1.19M.

Noah G. Levy's Trading History

MACK
Merrimack Pharmaceuticals
Jan 17, 2023―Informative Buy1.19M$16.94M
MACK
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 17, 2023Informative Buy$1.19M100,000$11.90+13.00%
Jul 15, 2022Informative Buy$18.20K3,095$5.88―
Jul 13, 2022Informative Buy$20.68K3,516$5.88―
Jul 11, 2022Informative Buy$14.82K2,478$5.98―
Jul 05, 2022Informative Buy$8.91K1,550$5.75―

You May Also Like

Noah G. Levy insider profile FAQ

What stocks does Noah G. Levy hold?
Noah G. Levy holds: MACK stocks.
What was Noah G. Levy’s latest transaction?
Noah G. Levy’s latest transaction was an Informative Buy of $1.19M.
What was Noah G. Levy's most profitable transaction?
Noah G. Levy’s most profitable transaction was an Informative Buy of MACK stock on January 17, 2023. The return on the trade was 13.00%.
What is Noah G. Levy's role in Merrimack Pharmaceuticals?
Noah G. Levy's role in Merrimack Pharmaceuticals is Director, See remarks.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.